Literature DB >> 19035968

Plasma lipids and inflammation in active inflammatory bowel diseases.

G Romanato1, M Scarpa, I Angriman, D Faggian, C Ruffolo, R Marin, S Zambon, S Basato, S Zanoni, T Filosa, F Pilon, E Manzato.   

Abstract

BACKGROUND: Ulcerative colitis (UC) and Crohn's disease (CD) can cause metabolic and inflammatory alterations. AIM: To evaluate the relationships between inflammatory parameters, plasma lipids and phospholipid fatty acid (FA) composition in patients with active UC and CD.
METHODS: Diet, the Harvey-Bradshaw Activity Index (HBAI), inflammatory parameters, lipoproteins and FA composition were assessed in 60 CD and 34 UC.
RESULTS: No differences in clinical parameters were observed in the two groups. Total cholesterol correlated inversely with the number of bowel movements in both groups and directly with BMI in UC. Arachidonic acid correlated inversely with HBAI in UC and total and HDL cholesterol were inversely related to C-reactive protein (CRP) in CD while HDL correlated with CRP in UC. Docosapentaenoic acid was the only polyunsaturated n-3 FA that was correlated to CRP in both groups. Total cholesterol was independently associated in the multiple regression analysis with the number of bowel movements and systemic inflammation.
CONCLUSIONS: Total and LDL cholesterol were lower in the active UC and CD than in the healthy subjects and were correlated with the systemic inflammatory status. Phospholipid FA composition was correlated to the systemic inflammatory status, but was unrelated to dietary intake and intestinal disease activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035968     DOI: 10.1111/j.1365-2036.2008.03886.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

Review 1.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

2.  Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.

Authors:  Efstratios Koutroumpakis; Claudia Ramos-Rivers; Miguel Regueiro; Jana G Hashash; Arthur Barrie; Jason Swoger; Leonard Baidoo; Marc Schwartz; Michael A Dunn; Ioannis E Koutroubakis; David G Binion
Journal:  Dig Dis Sci       Date:  2015-10-29       Impact factor: 3.199

Review 3.  Epidemiology, risk factors and management of cardiovascular diseases in IBD.

Authors:  Siddharth Singh; Iftikhar J Kullo; Darrell S Pardi; Edward V Loftus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

Review 4.  Cytokine Circuits in Cardiovascular Disease.

Authors:  Jesse W Williams; Li-Hao Huang; Gwendalyn J Randolph
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

5.  The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients.

Authors:  Dawn M Wiese; Bret A Lashner; Edith Lerner; Stephen J DeMichele; Douglas L Seidner
Journal:  Nutr Clin Pract       Date:  2011-08       Impact factor: 3.080

6.  Erythrocyte membrane phospholipid polyunsaturated fatty acids are related to plasma C-reactive protein and adiponectin in middle-aged German women and men.

Authors:  Cornelia Enzenbach; Janine Kröger; Vera Zietemann; Eugène H J M Jansen; Andreas Fritsche; Frank Döring; Heiner Boeing; Matthias B Schulze
Journal:  Eur J Nutr       Date:  2011-02-08       Impact factor: 5.614

7.  Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study.

Authors:  Ni Tien; Tien-Yuan Wu; Cheng-Li Lin; Chia-Jui Wu; Chung-Y Hsu; Yi-Jen Fang; Yun-Ping Lim
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 8.  HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases.

Authors:  Fabrizia Bonacina; Angela Pirillo; Alberico L Catapano; Giuseppe D Norata
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

9.  CPAG: software for leveraging pleiotropy in GWAS to reveal similarity between human traits links plasma fatty acids and intestinal inflammation.

Authors:  Liuyang Wang; Stefan H Oehlers; Scott T Espenschied; John F Rawls; David M Tobin; Dennis C Ko
Journal:  Genome Biol       Date:  2015-09-15       Impact factor: 13.583

10.  Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.

Authors:  Bruce E Sands; Jean-Frédéric Colombel; Christina Ha; Michel Farnier; Alessandro Armuzzi; Daniel Quirk; Gary S Friedman; Kenneth Kwok; Leonardo Salese; Chinyu Su; Pam R Taub
Journal:  Inflamm Bowel Dis       Date:  2021-05-17       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.